ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit

[1]  S. Hohnloser,et al.  New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation , 2008, Herz Kardiovaskuläre Erkrankungen.

[2]  P. McCarthy,et al.  Advances in surgical treatment of atrial fibrillation. , 2004, Stroke.

[3]  M. Pfeffer,et al.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, Journal of the American College of Cardiology.

[4]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[5]  M. Guerrero,et al.  Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency , 2006, Intensive Care Medicine.

[6]  Anders Odén,et al.  Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. , 2006, Thrombosis research.

[7]  D. Wyse,et al.  Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. , 2005, JAMA.

[8]  J. Mathew,et al.  Prophylaxis against postoperative atrial fibrillation: current progress and future directions. , 2005, JAMA.

[9]  R. Habib,et al.  Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery , 2005, Circulation.

[10]  E. Daoud,et al.  Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.

[11]  Dietrich Andresen,et al.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. , 2005, European heart journal.

[12]  E. Prystowsky,et al.  Rate versus rhythm control in the management of patients with atrial fibrillation , 2005, Nature Clinical Practice Cardiovascular Medicine.

[13]  M. Woodward,et al.  Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack , 2005, Stroke.

[14]  G. Lip,et al.  Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease , 2005, Thrombosis and Haemostasis.

[15]  D. Singer,et al.  Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.

[16]  P. Vestergaard,et al.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. , 2005, The American journal of medicine.

[17]  E. Kaufman,et al.  Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. , 2005, Archives of internal medicine.

[18]  Prashanthan Sanders,et al.  Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans , 2005, Circulation.

[19]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[20]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[21]  P. Teirstein,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.

[22]  R. Hart,et al.  Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas , 2005, Stroke.

[23]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[24]  Claus Schmitt,et al.  Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies , 2005, Circulation.

[25]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[26]  C. Pandozi,et al.  N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. , 2005, Journal of the American College of Cardiology.

[27]  D. Reda,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[28]  D. Lin,et al.  Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast , 2005, Journal of cardiovascular electrophysiology.

[29]  A. De Simone,et al.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[30]  Douglas Packer,et al.  Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.

[31]  M. Nieminen,et al.  Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[32]  Gianni Tognoni,et al.  Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). , 2005, American heart journal.

[33]  S. Connolly,et al.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. , 2005, American heart journal.

[34]  M. Nieminen,et al.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[35]  J. McMurray,et al.  Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.

[36]  Palle Petersen,et al.  Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. , 2005, JAMA.

[37]  Paul A Friedman,et al.  Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the , 2005, Circulation.

[38]  J. Halperin.  Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[39]  A. Sheikhzadeh,et al.  Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation , 1995, The International Journal of Cardiac Imaging.

[40]  D. Parish,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2005, JAMA.

[41]  G. Tsivgoulis,et al.  Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. , 2005, Age and ageing.

[42]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[43]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. , 2004, The New England journal of medicine.

[44]  Prashanthan Sanders,et al.  Techniques for Curative Treatment of Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[45]  J. Coromilas.  Obesity and atrial fibrillation: is one epidemic feeding the other? , 2004, JAMA.

[46]  Margaret C Fang,et al.  Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation , 2004, Annals of Internal Medicine.

[47]  F. Marchlinski,et al.  Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans , 2004, Circulation.

[48]  H. Schunkert,et al.  Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3 , 2004, Circulation.

[49]  Ottavio Alfieri,et al.  Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation: A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach , 2004, Circulation.

[50]  S. Bendahhou,et al.  Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. , 2004, American journal of human genetics.

[51]  A. Salvador,et al.  Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. , 2004, Journal of the American College of Cardiology.

[52]  Stanley Nattel,et al.  Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs , 2004, Circulation.

[53]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[54]  R. Damiano,et al.  A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. , 2004, The Journal of thoracic and cardiovascular surgery.

[55]  C. Lau,et al.  Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]). , 2004, The American journal of cardiology.

[56]  H. Crijns,et al.  Atrial Ultrastructural Changes During Experimental Atrial Tachycardia Depend on High Ventricular Rate , 2004, Journal of cardiovascular electrophysiology.

[57]  Vincenzo Santinelli,et al.  The Who, What, Why, and How‐To Guide for Circumferential Pulmonary Vein Ablation , 2004, Journal of cardiovascular electrophysiology.

[58]  U Schotten,et al.  “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat , 2004, Circulation.

[59]  R. D. Murray,et al.  Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. , 2004, The American journal of cardiology.

[60]  G. Lip,et al.  Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation , 2004, Heart.

[61]  P. Vardas,et al.  Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. , 2004, The American journal of cardiology.

[62]  P. Kowey,et al.  Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. , 2004, The American journal of cardiology.

[63]  Gabriele Vicedomini,et al.  Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. , 2004, Journal of the American College of Cardiology.

[64]  J. Hirsh,et al.  Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[65]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[66]  S. Themistoclakis,et al.  Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. , 2004, Journal of the American College of Cardiology.

[67]  A. Kalogeropoulos,et al.  Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. , 2004, Journal of the American College of Cardiology.

[68]  H. Heidbuchel,et al.  Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics , 2004, Heart.

[69]  A. Torbicki,et al.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.

[70]  A. d'Avila,et al.  Left Atrial–Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation , 2004, Journal of cardiovascular electrophysiology.

[71]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[72]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[73]  Paul A Friedman,et al.  Association of Atrial Fibrillation and Obstructive Sleep Apnea , 2004, Circulation.

[74]  Bruce M Psaty,et al.  Fish intake and risk of incident atrial fibrillation. , 2004, Circulation.

[75]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.

[76]  P. Sanders,et al.  Electrophysiologic and electroanatomic changes in the human atrium associated with age. , 2004, Journal of the American College of Cardiology.

[77]  Holly Yu,et al.  Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[78]  S. Hohnloser,et al.  Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. , 2004, Journal of the American College of Cardiology.

[79]  G. Boriani,et al.  Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. , 2004, European heart journal.

[80]  Federico Lombardi,et al.  Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation. , 2004, European heart journal.

[81]  Ralph B D'Agostino,et al.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.

[82]  M. Chung,et al.  Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. , 2004, The American journal of cardiology.

[83]  B. Wożakowska-Kapłon.  Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. , 2004, The American journal of cardiology.

[84]  J. Davignon.  Beneficial Cardiovascular Pleiotropic Effects of Statins , 2004, Circulation.

[85]  O. Alfieri,et al.  Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation , 2004, Circulation.

[86]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[87]  T. Sacchi,et al.  Female preponderance in ibutilide-induced torsade de pointes. , 2004, International journal of cardiology.

[88]  D. Bush,et al.  Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study). , 2004, The American journal of cardiology.

[89]  A. Zaman,et al.  Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. , 2004, American heart journal.

[90]  J. Mcanulty,et al.  Reversal of Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation , 2004, Cardiovascular Electrophysiology.

[91]  T. Horinouchi,et al.  C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? , 2004, Japanese heart journal.

[92]  M. Josephson,et al.  Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. , 2004, American Journal of Cardiology.

[93]  K. Murray,et al.  Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[94]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[95]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[96]  A. Camm,et al.  The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. , 2004, Journal of the American College of Cardiology.

[97]  Thomas Lavergne,et al.  Cost of care distribution in atrial fibrillation patients: the COCAF study. , 2004, American heart journal.

[98]  M. Jazayeri,et al.  The Impact of Atrial Prevention and Termination Therapies on Atrial Tachyarrhythmia Burden in Patients Receiving a Dual-Chamber Defibrillator for Ventricular Arrhythmias , 2004, Journal of Interventional Cardiac Electrophysiology.

[99]  P. Koudstaal,et al.  Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial , 2004, Stroke.

[100]  J. Tamargo,et al.  Pharmacology of Cardiac Potassium Channels , 2003 .

[101]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[102]  P. Vardas,et al.  Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation. , 2004, Journal of the American College of Cardiology.

[103]  R. Villareal,et al.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[104]  A. Camm,et al.  Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification , 2004, Circulation.

[105]  W. Lehmacher,et al.  Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial , 2004, Circulation.

[106]  F. Marín,et al.  Effects of Pretreatment with Intravenous Flecainide on Efficacy of External Cardioversion of Persistent Atrial Fibrillation , 2004, Pacing and clinical electrophysiology : PACE.

[107]  Prashanthan Sanders,et al.  Atrial Fibrillation Originating From Persistent Left Superior Vena Cava , 2004, Circulation.

[108]  J. McMurray,et al.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK , 2004, Heart.

[109]  A. Go,et al.  Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. , 2004, Journal of the American College of Cardiology.

[110]  L. Tamariz,et al.  Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.

[111]  J. Cox.  Cardiac surgery for arrhythmias. , 2004, Journal of cardiovascular electrophysiology.

[112]  P. Vardas,et al.  Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. , 2004, Chest.

[113]  F. Esmailian,et al.  Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation , 2004, Circulation.

[114]  O. Alfieri,et al.  Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation , 2004, Circulation.

[115]  P. Vardas,et al.  Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[116]  Otto Kamp,et al.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.

[117]  R. Schilling,et al.  Spontaneous termination of ventricular fibrillation , 2004, Heart.

[118]  C. Israel,et al.  Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.

[119]  M. Woodward,et al.  Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.

[120]  D. Stakos,et al.  Atrial Fibrillation and Hypercoagulability: Dependent on Clinical Factors or/and on Genetic Alterations? , 2003, Journal of Thrombosis and Thrombolysis.

[121]  M. Janion,et al.  Efficacy of Biphasic Shock for Transthoracic Cardioversion of Persistent Atrial Fibrillation: , 2003, Pacing and clinical electrophysiology : PACE.

[122]  Paul J. Wang,et al.  Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction. , 2003, American heart journal.

[123]  K. Saku,et al.  The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. , 2003, Cardiovascular research.

[124]  D. Singer,et al.  Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2003, Journal of Thrombosis and Thrombolysis.

[125]  Peng-Sheng Chen,et al.  Selective Atrionodal Input Ablation for Induction of Proximal Complete Heart Block with Stable Junctional Escape Rhythm in Patients with Uncontrolled Atrial Fibrillation , 2003, Journal of Interventional Cardiac Electrophysiology.

[126]  P. Vardas,et al.  Pharmacological Cardioversion of Recent Onset Atrial Fibrillation with Intravenous Amiodarone in Patients Receiving Long-Term Amiodarone Therapy: Is It Reasonable? , 2003, Journal of Interventional Cardiac Electrophysiology.

[127]  A. John Camm,et al.  Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management , 2000, Journal of Interventional Cardiac Electrophysiology.

[128]  H. Crijns,et al.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: A randomized, double-blind study , 1996, Cardiovascular Drugs and Therapy.

[129]  N. Rehnqvist,et al.  Sotalol versus quinidine in the maintenance of sinus rhythm after direct current conversion of atrial fibrillation , 1990, Cardiovascular Drugs and Therapy.

[130]  S. Yusuf,et al.  Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. , 2004, The Cochrane database of systematic reviews.

[131]  B. Lüderitz,et al.  Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. , 2004, European heart journal.

[132]  J. Blanc,et al.  Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[133]  Pharmacological approaches in the treatment of atrial fibrillation. , 2004, Current medicinal chemistry.

[134]  Theoretical possibilities for the development of novel antiarrhythmic drugs. , 2004, Current medicinal chemistry.

[135]  Kenneth A. Ellenbogen,et al.  The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation , 2004, Journal of Interventional Cardiac Electrophysiology.

[136]  P. Vardas,et al.  Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study , 2004, Cardiovascular Drugs and Therapy.

[137]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.

[138]  I. V. Van Gelder,et al.  Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[139]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[140]  R. Goldberg,et al.  Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. , 2003, The American journal of cardiology.

[141]  G. Jensen,et al.  Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). , 2003, The American journal of cardiology.

[142]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[143]  G. Naccarelli,et al.  Atrial Fibrillation in Heart Failure: , 2003, Journal of cardiovascular electrophysiology.

[144]  A. Capucci,et al.  Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation. , 2003, The American journal of cardiology.

[145]  J. Boineau,et al.  The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. , 2003, The Journal of thoracic and cardiovascular surgery.

[146]  G. Naccarelli,et al.  Atrial fibrillation in heart failure: prognostic significance and management. , 2003 .

[147]  Douglas L Packer,et al.  Progress in Nonpharmacologic Therapy of Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[148]  C. Lau,et al.  Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. , 2003, The American journal of cardiology.

[149]  Wen-Chung Yu,et al.  Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. , 2003, European heart journal.

[150]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[151]  S. Olsson,et al.  Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial , 2003, The Lancet.

[152]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[153]  G. Paxinos,et al.  Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. , 2003, The American journal of cardiology.

[154]  Andrew S. Mugglin,et al.  Combined Efficacy of Atrial Septal Lead Placement and Atrial Pacing Algorithms for Prevention of Paroxysmal Atrial Tachyarrhythmia , 2003, Journal of cardiovascular electrophysiology.

[155]  S. Nattel,et al.  Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. , 2003, Cardiovascular research.

[156]  G. Jensen,et al.  Rising Rates of Hospital Admissions for Atrial Fibrillation , 2003, Epidemiology.

[157]  R. Page,et al.  Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. , 2003, The American journal of cardiology.

[158]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[159]  S. Ogawa,et al.  β-Blockers are effective in congestive heart failure patients with atrial fibrillation , 2003 .

[160]  D. Packer,et al.  Left Atrial Appendage Obliteration in Atrial Fibrillation Thoracoscopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation , 2003 .

[161]  W. Maisel.  Autonomic modulation preceding the onset of atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[162]  Prashanthan Sanders,et al.  Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans , 2003, Circulation.

[163]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[164]  J. Halperin,et al.  Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). , 2003, American heart journal.

[165]  Y. Iesaka,et al.  Reentrant Tachycardia in Pulmonary Veins of Patients with Paroxysmal Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[166]  S. Connolly,et al.  Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials. , 2003, American heart journal.

[167]  H. Crijns,et al.  Recent Advances in Drug Therapy for Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[168]  P. Dorian,et al.  Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. , 2003, Cardiac electrophysiology review.

[169]  Ralph B D'Agostino,et al.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. , 2003, JAMA.

[170]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[171]  S. Hohnloser,et al.  Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. , 2003, European heart journal.

[172]  M. di Mauro,et al.  VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). , 2003, European heart journal.

[173]  J. Messenger,et al.  A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). , 2003, Journal of the American College of Cardiology.

[174]  A. Capucci,et al.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.

[175]  Ottavio Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.

[176]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[177]  B. Gersh,et al.  Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction. , 2003, The American journal of cardiology.

[178]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[179]  James B Seward,et al.  The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. , 2003, Journal of the American College of Cardiology.

[180]  M. Haissaguerre,et al.  Nonpulmonary Vein Foci: , 2003, Pacing and clinical electrophysiology : PACE.

[181]  Wei-Shiang Lin,et al.  Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy , 2003, Circulation.

[182]  G. Lip,et al.  Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation , 2003, Circulation.

[183]  Douglas L Packer,et al.  Familial atrial fibrillation is a genetically heterogeneous disorder. , 2003, Journal of the American College of Cardiology.

[184]  K. Arakawa,et al.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[185]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[186]  P. Ellinor,et al.  Locus for Atrial Fibrillation Maps to Chromosome 6q14‐16 , 2003, Circulation.

[187]  A. Ducharme,et al.  Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.

[188]  M. Josephson,et al.  Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. , 2003, The American journal of cardiology.

[189]  A. Mattioli,et al.  Left atrial size and function after spontaneous cardioversion of atrial fibrillation and their relation to N-terminal atrial natriuretic peptide. , 2003, The American journal of cardiology.

[190]  I. Khan,et al.  Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[191]  Keishi Kubo,et al.  Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease , 2003, Journal of cardiovascular electrophysiology.

[192]  L. Mestroni.  Genomic medicine and atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[193]  Sander Verheule,et al.  Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation , 2003, Circulation.

[194]  M. Bulsara,et al.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.

[195]  J. Pezzullo,et al.  Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. , 2003, The American journal of cardiology.

[196]  Nobuo Fukuda,et al.  Relation of Age and Sex to Atrial Electrophysiological Properties in Patients with No History of Atrial Fibrillation , 2003, Pacing and clinical electrophysiology : PACE.

[197]  I. Khan.  Atrial stunning: determinants and cellular mechanisms. , 2003, American heart journal.

[198]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[199]  A. Laupacis,et al.  A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. , 2003, Archives of internal medicine.

[200]  Maurits A. Allessie,et al.  Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat , 2003, Circulation.

[201]  G. Guyatt,et al.  Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. , 2003, Archives of internal medicine.

[202]  D. Wolbrette.  Treatment of arrhythmias during pregnancy. , 2003, Current women's health reports.

[203]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[204]  G. Naccarelli,et al.  Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. , 2003, The American journal of cardiology.

[205]  S. Nattel,et al.  Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone , 2003, Circulation.

[206]  A. Kamkin,et al.  Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation , 2003, Pflügers Archiv.

[207]  S. Nattel.  Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[208]  S. Nattel,et al.  Pharmacological Prevention of Atrial Tachycardia Induced Atrial Remodeling as a Potential Therapeutic Strategy , 2003, Pacing and clinical electrophysiology : PACE.

[209]  Ying Wang,et al.  KCNQ1 gain-of-function mutation in familial atrial fibrillation. , 2003, Science.

[210]  V. Fuster,et al.  Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. , 2003, Journal of the American College of Cardiology.

[211]  Hendrik Bonnemeier,et al.  Autonomic tone variations before the onset of paroxysmal atrial fibrillation. , 2003, Circulation.

[212]  S. Owada,et al.  [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration]. , 2003, Journal of cardiology.

[213]  Patrick Gautier,et al.  Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells , 2003, Journal of cardiovascular pharmacology.

[214]  I. Khan.  Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[215]  Hideyuki Hara,et al.  Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[216]  R. Platt,et al.  Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. , 2003, Journal of the American College of Cardiology.

[217]  Haran Burri,et al.  Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[218]  A. Hedman,et al.  Predicting the risk of atrial fibrillation after coronary artery bypass surgery , 2003, Scandinavian cardiovascular journal : SCJ.

[219]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. , 2003, American heart journal.

[220]  S. Hohnloser,et al.  Beta-blocker therapy in atrial fibrillation. , 2003, Pacing and clinical electrophysiology : PACE.

[221]  Beta-blockers are effective in congestive heart failure patients with atrial fibrillation. , 2003, Journal of cardiac failure.

[222]  S. Connolly,et al.  Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide. , 2003, Circulation.

[223]  J. Halperin,et al.  Obliteration of the left atrial appendage for prevention of thromboembolism. , 2003, Journal of the American College of Cardiology.

[224]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.

[225]  G. Lip,et al.  Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). , 2002, The American journal of cardiology.

[226]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[227]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[228]  J. Debatin,et al.  Detection and characterization of intracardiac thrombi on MR imaging. , 2002, AJR. American journal of roentgenology.

[229]  Carl van Walraven,et al.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.

[230]  James B Seward,et al.  Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.

[231]  Michel Haïssaguerre,et al.  Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation , 2002, Circulation.

[232]  M. Jensen-Urstad,et al.  Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. , 2002, The American journal of medicine.

[233]  A. Goette,et al.  Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation , 2002, Circulation.

[234]  G. Lip,et al.  Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors , 2002, Circulation.

[235]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[236]  H. Arnesen,et al.  Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.

[237]  D. Wyse,et al.  Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. , 2002, Journal of the American College of Cardiology.

[238]  F. Morady,et al.  Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion , 2002, Journal of cardiovascular pharmacology and therapeutics.

[239]  A. Zanchetti,et al.  Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy , 2002, Journal of hypertension.

[240]  G. Uijen,et al.  Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial Infarction: Results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial , 2002, Circulation.

[241]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[242]  D. Grobbee,et al.  Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial , 2002, The Lancet.

[243]  R. Kerber,et al.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. , 2002, Journal of the American College of Cardiology.

[244]  Claus Schmitt,et al.  Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. , 2002, The American journal of cardiology.

[245]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[246]  M. Allessie,et al.  Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.

[247]  G. Opolski,et al.  Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation. , 2002, International journal of cardiology.

[248]  P. Vardas,et al.  Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. , 2002, European heart journal.

[249]  Harry J G M Crijns,et al.  Molecular mechanisms of remodeling in human atrial fibrillation. , 2002, Cardiovascular research.

[250]  S. Nattel,et al.  Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.

[251]  N. Kanuru,et al.  Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. , 2002, Journal of the American College of Cardiology.

[252]  S. Hohnloser,et al.  Atrial Fibrillation and Congestive Heart Failure: Specific Considerations at the Intersection of Two Common and Important Cardiac Disease Sets , 2002, Journal of cardiovascular electrophysiology.

[253]  Takashi Sugamori,et al.  High Plasma Brain Natriuretic Polypeptide Level as a Marker of Risk for Thromboembolism in Patients With Nonvalvular Atrial Fibrillation , 2002, Stroke.

[254]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[255]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[256]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[257]  J. Gore,et al.  Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. , 2002, American heart journal.

[258]  Extended distribution of prolonged and fractionated right atrial electrograms predicts development of chronic atrial fibrillation in patients with idiopathic paroxysmal atrial fibrillation. , 2002, Journal of cardiovascular electrophysiology.

[259]  M. Jensen-Urstad,et al.  Transient Proarrhythmic State Following Atrioventricular Junctional Radiofrequency Ablation , 2002, Pacing and clinical electrophysiology : PACE.

[260]  N. Peters,et al.  Atrial fibrillation: strategies to control, combat, and cure , 2002, The Lancet.

[261]  M. Ezekowitz,et al.  Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study , 2002, Circulation.

[262]  J. Bourke,et al.  Paroxysmal Cycle Length Shortening in the Pulmonary Veins During Atrial Fibrillation Correlates with Arrhythmogenic Triggering Foci in Sinus Rhythm , 2002, Journal of cardiovascular electrophysiology.

[263]  S. Nattel.  New ideas about atrial fibrillation 50 years on , 2002, Nature.

[264]  S. Spinler,et al.  Conversion of Recent‐Onset Atrial Fibrillation with Intravenous Amiodarone: A Meta‐Analysis of Randomized Controlled Trials , 2002, Pharmacotherapy.

[265]  M. Dunn,et al.  Atrial mechanical performance following internal and external cardioversion of atrial fibrillation: its relationship to peripheral embolization and acute cerebrovascular accident. , 2002, Chest.

[266]  Stanley Nattel,et al.  New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. , 2002, Drugs.

[267]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[268]  Y C Chen,et al.  Effects of Rapid Atrial Pacing on the Arrhythmogenic Activity of Single Cardiomyocytes From Pulmonary Veins: Implication in Initiation of Atrial Fibrillation , 2001, Circulation.

[269]  A. Capucci,et al.  Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. , 2001, American heart journal.

[270]  H. Heidbüchel,et al.  Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[271]  J. Dernellis,et al.  C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation , 2001, Acta cardiologica.

[272]  Pablo A. Chiale,et al.  Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial , 2001, Journal of cardiovascular pharmacology and therapeutics.

[273]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[274]  S. Connolly,et al.  Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation. , 2001, The American journal of cardiology.

[275]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[276]  M. Rosenqvist,et al.  Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. , 2001, European heart journal.

[277]  A. Mallet,et al.  Anticoagulant (Fluindione)-Aspirin Combination in Patients with High-Risk Atrial Fibrillation , 2001, Cerebrovascular Diseases.

[278]  S. Olsson,et al.  Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation. , 2001, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[279]  R. Page,et al.  Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. , 2001, American heart journal.

[280]  D. Oral,et al.  Lengthening of intraatrial conduction time in atrial fibrillation and its relation with early recurrence of atrial fibrillation. , 2001, Japanese heart journal.

[281]  F. Pelosi,et al.  Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation. , 2001, The American journal of cardiology.

[282]  J. Haefliger,et al.  Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. , 2001, Journal of the American College of Cardiology.

[283]  S. Adler,et al.  Prevention of Chronic Atrial Fibrillation by Pacing in the Region of Bachmann's Bundle: Results of a Multicenter Randomized Trial , 2001, Journal of cardiovascular electrophysiology.

[284]  P. Venugopalan,et al.  Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. , 2001, European journal of heart failure.

[285]  C. Schmitt,et al.  Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. , 2001, European heart journal.

[286]  A. Skanes,et al.  Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. , 2001, American heart journal.

[287]  L. Køber,et al.  Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.

[288]  P. Vardas,et al.  Sinus Pacemaker Function after Cardioversion of Chronic Atrial Fibrillation: Is Sinus Node Remodeling Related with Recurrence? , 2001, Journal of cardiovascular electrophysiology.

[289]  R. Tieleman,et al.  VERDICT: The Verapamil versus Digoxin Cardioversion Trial: A Randomized Study on the Role of Calcium Lowering for Maintenance of Sinus Rhythm after Cardioversion of Persistent Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.

[290]  A. Goette,et al.  Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.

[291]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[292]  M. Mansour,et al.  Left-to-Right Gradient of Atrial Frequencies During Acute Atrial Fibrillation in the Isolated Sheep Heart , 2001, Circulation.

[293]  C. Lau,et al.  Comparison Of Digoxin Versus Low‐Dose Amiodarone For Ventricular Rate Control In Patients With Chronic Atrial Fibrillation , 2001, Clinical and experimental pharmacology & physiology.

[294]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[295]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[296]  R Lazzara,et al.  Focal Atrial Fibrillation: Experimental Evidence for a Pathophysiologic Role of the Autonomic Nervous System , 2001, Journal of cardiovascular electrophysiology.

[297]  C. Tai,et al.  Prolonged fractionation of paced right atrial electrograms in patients with atrial flutter and fibrillation. , 2001, Journal of the American College of Cardiology.

[298]  J M de Bakker,et al.  Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[299]  S Capewell,et al.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. , 2001, European heart journal.

[300]  M. Jensen-Urstad,et al.  factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation , 2001, Clinical cardiology.

[301]  R. Grimm,et al.  Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[302]  M. Zimmermann,et al.  Fluctuation in Autonomic Tone is a Major Determinant of Sustained Atrial Arrhythmias in Patients with Focal Ectopy Originating from the Pulmonary Veins , 2001, Journal of cardiovascular electrophysiology.

[303]  A. Leaf,et al.  Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. , 2001, Journal of lipid research.

[304]  J. Halperin,et al.  Atrial fibrillation and stroke : concepts and controversies. , 2001, Stroke.

[305]  P. Kowey,et al.  Clinical Outcome of Patients Who Develop PAF After CABG Surgery , 2001, Pacing and clinical electrophysiology : PACE.

[306]  I. Khan.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[307]  Z. Yuan,et al.  Risk of stroke in patients with atrial flutter. , 2001, The American journal of cardiology.

[308]  R. Cappato,et al.  Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. , 2001, Journal of the American College of Cardiology.

[309]  A. Waldo,et al.  Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation. , 2001, The American journal of cardiology.

[310]  P. Venugopalan,et al.  Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements. , 2001, International journal of cardiology.

[311]  E. Ohman,et al.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. , 2001, Chest.

[312]  M. Allessie,et al.  Mapping of atrial fibrillation. , 2001, Annali dell'Istituto superiore di sanita.

[313]  A. Laupacis,et al.  Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks , 2005, The Cochrane database of systematic reviews.

[314]  Kenneth Egstrup,et al.  Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial , 2000, The Lancet.

[315]  I. V. Van Gelder,et al.  Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. , 2000, The American journal of cardiology.

[316]  R Lazzara,et al.  Catheter Ablation of Cardiac Autonomic Nerves for Prevention of Vagal Atrial Fibrillation , 2000, Circulation.

[317]  S. Hohnloser,et al.  Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.

[318]  S Chierchia,et al.  Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation , 2000, Circulation.

[319]  J Clémenty,et al.  Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins , 2000, Circulation.

[320]  R. Beyth,et al.  A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin , 2000, Annals of Internal Medicine.

[321]  M. Brodsky,et al.  Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[322]  E. Daoud,et al.  Effect of Verapamil on Immediate Recurrence of Atrial Fibrillation , 2000, Journal of cardiovascular electrophysiology.

[323]  Marlene R. Miller,et al.  Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. , 2000, The Journal of family practice.

[324]  M. Kinoshita,et al.  Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. , 2000, Japanese circulation journal.

[325]  D. Haines,et al.  Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation , 2000, Circulation.

[326]  A. Capucci,et al.  Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. , 2000, American Heart Journal.

[327]  P. Vardas,et al.  Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study , 2000, Heart.

[328]  J. Bermejo,et al.  Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. , 2000, The American journal of cardiology.

[329]  S. Connolly,et al.  Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. , 2000, Journal of the American College of Cardiology.

[330]  A. Aggarwal.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[331]  C. Lau,et al.  Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. , 2000, Circulation.

[332]  R. Page,et al.  Initial energy for elective external cardioversion of persistent atrial fibrillation. , 2000, The American journal of cardiology.

[333]  J. Webster,et al.  Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. , 2000, QJM : monthly journal of the Association of Physicians.

[334]  I. V. Van Gelder,et al.  Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. , 2000, European heart journal.

[335]  J. Halperin,et al.  Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. , 2000, The American journal of medicine.

[336]  D. Singer,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.

[337]  Wen-Chung Yu,et al.  Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. , 2000, Circulation.

[338]  K. Weber.  Fibrosis and hypertensive heart disease , 2000, Current opinion in cardiology.

[339]  K. Stangl,et al.  Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[340]  A. Goette,et al.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.

[341]  C. Blomström-Lundqvist,et al.  Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. , 2000, Circulation.

[342]  A. Natale,et al.  Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. , 2000, Journal of the American College of Cardiology.

[343]  P. Vardas,et al.  Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. , 2000, Chest.

[344]  T Fahey,et al.  The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. , 2000, BMJ : British Medical Journal.

[345]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[346]  E. Prystowsky,et al.  Management of atrial fibrillation: therapeutic options and clinical decisions. , 2000, The American journal of cardiology.

[347]  G. Naccarelli,et al.  Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. , 2000, The American journal of cardiology.

[348]  A. Bloch,et al.  Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. , 2000, American heart journal.

[349]  I. Black.  Spontaneous Echo Contrast: Where There's Smoke There's Fire , 2000, Echocardiography.

[350]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[351]  H. Crijns,et al.  Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter. , 2000, The American journal of cardiology.

[352]  M. Enriquez-Sarano,et al.  Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. , 2000, Journal of the American College of Cardiology.

[353]  K. Lees,et al.  Identification of echocardiographic "smoke" in a bench model with transcranial Doppler ultrasound. , 2000, Stroke.

[354]  J Clémenty,et al.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. , 2000, Circulation.

[355]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[356]  G. Kay,et al.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[357]  R. Hauer,et al.  Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. , 2000, Circulation.

[358]  K A Schulman,et al.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.

[359]  L. Zaputović,et al.  Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon , 2000, Pacing and clinical electrophysiology : PACE.

[360]  M. Niemelä,et al.  Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. , 2000, The American journal of cardiology.

[361]  H. White,et al.  Serum troponins T and I after elective cardioversion. , 2000, European heart journal.

[362]  N. Ishikawa,et al.  Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.

[363]  H. Ogita,et al.  Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. , 2000, Journal of the American College of Cardiology.

[364]  RaviMandapati,et al.  Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart , 2000 .

[365]  J. Rothrock,et al.  Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies , 2000, Cerebrovascular Diseases.

[366]  S. Lévy,et al.  Classification system of atrial fibrillation. , 2000, Current opinion in cardiology.

[367]  Marlene R. Miller,et al.  The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.

[368]  A. Capucci,et al.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. , 2000, European heart journal.

[369]  J. Halperin,et al.  Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.

[370]  Sonia S Anand,et al.  Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.

[371]  J. Halperin,et al.  Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[372]  B K Khandheria,et al.  Echocardiographic assessment of the left atrial appendage. , 1999, Journal of the American College of Cardiology.

[373]  G. Botto,et al.  External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements , 1999, Heart.

[374]  C. Tai,et al.  Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. , 1999, Circulation.

[375]  Bramahn . Singh,et al.  Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. , 1999, Circulation.

[376]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[377]  I. V. Van Gelder,et al.  Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. , 1999, The American journal of cardiology.

[378]  R. Hart,et al.  Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention , 1999, Annals of Internal Medicine.

[379]  C. Tai,et al.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.

[380]  A. Natale,et al.  Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. , 1999, The American journal of cardiology.

[381]  M. Di leo,et al.  Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. , 1999, The American journal of cardiology.

[382]  J. Blanc,et al.  Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group. , 1999, The American journal of cardiology.

[383]  A. Natale,et al.  AV Node Ablation and Pacemaker Implantation After Withdrawal of Effective Rate‐Control Medications for Chronic Atrial Fibrillation: Effect on Quality of Life and Exercise Performance , 1999, Pacing and clinical electrophysiology : PACE.

[384]  John Calvin Reed,et al.  Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.

[385]  J. Knottnerus,et al.  Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin , 1999, BMJ.

[386]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[387]  李永军,et al.  Atrial Fibrillation , 1999 .

[388]  G F Michaud,et al.  Electrocardiographic differentiation of atrial flutter from atrial fibrillation by physicians. , 1999, Journal of electrocardiology.

[389]  J. Gorter,et al.  Major bleeding during anticoagulation after cerebral ischemia , 1999, Neurology.

[390]  I. V. Van Gelder,et al.  Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation , 1999, Heart.

[391]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[392]  S Chierchia,et al.  Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. , 1999, Circulation.

[393]  M. Gasparini,et al.  Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. , 1999, Journal of the American College of Cardiology.

[394]  Vince Paul,et al.  Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. , 1999, The American journal of cardiology.

[395]  T. Guarnieri,et al.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[396]  J. Williams,et al.  Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. , 1999, The American journal of cardiology.

[397]  C. Tai,et al.  Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. , 1999, The American journal of cardiology.

[398]  R. Steeds,et al.  An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation , 1999, Heart.

[399]  P. Kowey,et al.  Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. , 1999, Circulation.

[400]  L. Køber,et al.  Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[401]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[402]  M. Rosenqvist,et al.  Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation. , 1999, The American journal of cardiology.

[403]  V. Barriales,et al.  Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. , 1999, American heart journal.

[404]  P. Petersen,et al.  Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[405]  O. Benavente,et al.  Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis , 1999, Cerebrovascular Diseases.

[406]  F. Morady,et al.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.

[407]  S. Lévy,et al.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[408]  B. Nørgaard,et al.  Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial , 1999 .

[409]  J Melo,et al.  Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[410]  R McBride,et al.  Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1999, Stroke.

[411]  S. Connolly,et al.  Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. , 1999, Circulation.

[412]  D. Armstrong,et al.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation , 1999, BMJ.

[413]  M. Piccoli,et al.  Analysis of Heart Rate Variability Five Minutes Before the Onset of Paroxysmal Atrial Fibrillation , 1999, Pacing and clinical electrophysiology : PACE.

[414]  L. Køber,et al.  The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. , 1999, European heart journal.

[415]  S H Lee,et al.  Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. , 1999, Cardiovascular research.

[416]  J. Halperin,et al.  Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. , 1999, Stroke.

[417]  R. Holder,et al.  Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. , 1999, Circulation.

[418]  P. Vardas,et al.  Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. , 1999, Journal of the American College of Cardiology.

[419]  H. Calkins,et al.  A new system for catheter ablation of atrial fibrillation. , 1999, The American journal of cardiology.

[420]  E. Prystowsky,et al.  Sotalol: An important new antiarrhythmic. , 1999, American Heart Journal.

[421]  J. Halperin,et al.  Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. , 1999, American heart journal.

[422]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[423]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[424]  N. Saoudi,et al.  Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. , 1999, Circulation.

[425]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[426]  A. Capucci,et al.  The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation. , 1999, Current opinion in cardiology.

[427]  J. Boineau,et al.  Radial approach: a new concept in surgical treatment for atrial fibrillation I. Concept, anatomic and physiologic bases and development of a procedure. , 1999, The Annals of thoracic surgery.

[428]  P. Vardas,et al.  Efficacy of amiodarone for the termination of persistent atrial fibrillation. , 1999, The American journal of cardiology.

[429]  S. Lansman,et al.  Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. , 1999, Journal of the American College of Cardiology.

[430]  B. Nørgaard,et al.  Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. , 1999, American heart journal.

[431]  P. Podrid.  Prevention of postoperative atrial fibrillation: what is the best approach? , 1999, Journal of the American College of Cardiology.

[432]  R. Kronmal,et al.  Stroke risk in an elderly population with atrial fibrillation , 1999, Journal of General Internal Medicine.

[433]  P. Schweitzer,et al.  Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. , 1998, The American journal of cardiology.

[434]  P C Deedwania,et al.  Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.

[435]  S. Saksena,et al.  Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. , 1998, Journal of the American College of Cardiology.

[436]  A. Nussbacher,et al.  Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. , 1998, International journal of cardiology.

[437]  E. Antman,et al.  Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[438]  D. Shah,et al.  Long‐Term Follow‐Up After Right Atrial Radiofrequency Catheter Treatment of Paroxysmal Atrial Fibrillation , 1998, Pacing and clinical electrophysiology : PACE.

[439]  B. Winters,et al.  &ggr;‐Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias , 1998, Anesthesiology.

[440]  M. Noble,et al.  Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. , 1998, Circulation.

[441]  S. Connolly,et al.  The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. , 1998, The American journal of cardiology.

[442]  Rose Anne Kenny,et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[443]  B. Herweg,et al.  Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. , 1998, The American journal of cardiology.

[444]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[445]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[446]  S. Lévy,et al.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[447]  M A Waclawiw,et al.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[448]  B. Mcgovern,et al.  Antiarrhythmic drug therapy in pregnancy and lactation. , 1998, The American journal of cardiology.

[449]  G. Nante,et al.  Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. , 1998, The American journal of cardiology.

[450]  S. Hohnloser,et al.  Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial Fibrillation. , 1998, Journal of cardiovascular electrophysiology.

[451]  H. Mond,et al.  Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. , 1998, Journal of the American College of Cardiology.

[452]  G Van Nooten,et al.  Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. , 1998, The American journal of cardiology.

[453]  K. Stangl,et al.  Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation , 1998, Heart.

[454]  H. Lambert,et al.  Effect of Electrode Length on Atrial Defibrillation Thresholds , 1998, Journal of cardiovascular electrophysiology.

[455]  F. Paganelli,et al.  Antibodies Against Myosin in Sera of Patients with Idiopathic Paroxysmal Atrial Fibrillation , 1998, Journal of cardiovascular electrophysiology.

[456]  J. Halperin,et al.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[457]  M. Gammage,et al.  Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation , 1998, Heart.

[458]  G. Lupi,et al.  Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. , 1998, The American journal of cardiology.

[459]  T. Ganiats,et al.  Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. , 1998, American heart journal.

[460]  P. Kowey,et al.  Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. , 1998, Journal of the American College of Cardiology.

[461]  K. Harjai,et al.  Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. , 1998, The American journal of cardiology.

[462]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.

[463]  M. Brainin,et al.  Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation , 1998, Annals of Internal Medicine.

[464]  K. Ellenbogen,et al.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[465]  H. Wellens,et al.  Immediate Reinitiation of Atrial Fibrillation Following Internal Atrial Defibrillation , 1998, Journal of cardiovascular electrophysiology.

[466]  H. Crijns,et al.  Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. , 1998, International journal of cardiology.

[467]  A. Camm,et al.  Classification of Atrial Fibrillation , 1997, The American journal of cardiology.

[468]  L. Goldman,et al.  Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. , 1998, The New England journal of medicine.

[469]  G. Kay,et al.  Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. , 1998, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.

[470]  P. Goethals,et al.  Drug-induced Brugada syndrome. , 1998, Acta cardiologica.

[471]  A. Capucci.  Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. , 1998, American Journal of Cardiology.

[472]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[473]  R. Cheung.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. , 1998, JAMA.

[474]  V. Boyko,et al.  Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. , 1998, Circulation.

[475]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. , 1998, The New England journal of medicine.

[476]  E. Picano,et al.  Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy. , 1997, Circulation.

[477]  K. Ellenbogen,et al.  Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. , 1997, Circulation.

[478]  L. Shaw,et al.  Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. , 1997, The American journal of cardiology.

[479]  O. Benavente,et al.  Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation. , 1997, Journal of the neurological sciences.

[480]  M R Franz,et al.  Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.

[481]  B. Olshansky,et al.  Thromboembolism in chronic atrial flutter: is the risk underestimated? , 1997, Journal of the American College of Cardiology.

[482]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[483]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[484]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. , 1997, Circulation.

[485]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[486]  S Nattel,et al.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.

[487]  F. Martin,et al.  Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. , 1997, European heart journal.

[488]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[489]  Jyh‐Hong Chen,et al.  Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. , 1997, The American journal of cardiology.

[490]  S. Saksena,et al.  Internal Atrial Defibrillation: Effect on Sinus and Atrioventricular Nodal Function and Implanted Cardiac Pacemakers , 1997, Pacing and clinical electrophysiology : PACE.

[491]  S. Lévy.  Factors Predisposing to the Development of Atrial Fibrillation , 1997, Pacing and clinical electrophysiology : PACE.

[492]  F. Morady,et al.  Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. , 1997, Circulation.

[493]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[494]  R. Califf,et al.  Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.

[495]  M. Kinoshita,et al.  Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. , 1997, Japanese circulation journal.

[496]  SamuelLévy,et al.  Low-Energy Cardioversion of Spontaneous Atrial Fibrillation , 1997 .

[497]  S. Lévy,et al.  Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. , 1997, Circulation.

[498]  C. January,et al.  Adverse effects of low dose amiodarone: a meta-analysis. , 1997, Journal of the American College of Cardiology.

[499]  M. Woodward,et al.  EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[500]  R. Tracy,et al.  Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1997, Stroke.

[501]  P. Mills,et al.  The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. , 1997, Heart.

[502]  C. Upshaw,et al.  Hemodynamic changes after cardioversion of chronic atrial fibrillation. , 1997, Archives of internal medicine.

[503]  SergioCoccheri,et al.  Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation , 1997 .

[504]  G. Lip.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation , 2022 .

[505]  K. Berkin,et al.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. , 1997, Heart.

[506]  B. Drew,et al.  Risk of thromboembolism in chronic atrial flutter. , 1997, The American journal of cardiology.

[507]  A. Pezzano,et al.  Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. , 1997, Circulation.

[508]  A. Capucci,et al.  Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease , 1997, Annals of Internal Medicine.

[509]  A. Torbicki,et al.  Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct‐current cardioversion , 1997, Clinical cardiology.

[510]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[511]  L. Jordaens,et al.  Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. , 1997, European heart journal.

[512]  J. L. Huang,et al.  Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. , 1997, The American journal of cardiology.

[513]  R. Wanless,et al.  Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. , 1997, American heart journal.

[514]  J. Brugada,et al.  Identification of a genetic locus for familial atrial fibrillation. , 1997, The New England journal of medicine.

[515]  K. Ellenbogen,et al.  Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.

[516]  S. Lévy,et al.  Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[517]  S. Lévy,et al.  Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. , 1997, The American journal of cardiology.

[518]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[519]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[520]  J. Brugada,et al.  Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia. , 1997, The American journal of cardiology.

[521]  P. Grayburn,et al.  Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. , 1997, Circulation.

[522]  R. Stroobandt,et al.  Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. , 1997, The American journal of cardiology.

[523]  J Clémenty,et al.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation. , 1997, Circulation.

[524]  E. Prystowsky.  Atrioventricular Node Reentry: Physiology and Radiofrequency Ablation , 1997, Pacing and clinical electrophysiology : PACE.

[525]  M. Chung,et al.  Cardioversion Guided by Transesophageal Echocardiography: The ACUTE Pilot Study: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[526]  R. Falk,et al.  Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. , 1997, Journal of the American College of Cardiology.

[527]  L. Tsai,et al.  Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. , 1997, International journal of cardiology.

[528]  A. Capucci,et al.  Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. , 1997, International journal of cardiology.

[529]  T O Cheng,et al.  Predictors of atrial fibrillation after coronary artery surgery. , 1997, Circulation.

[530]  The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. , 1997, Archives of internal medicine.

[531]  Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. , 1997, European heart journal.

[532]  S. Amitani,et al.  Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[533]  C. Forbes,et al.  EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKE , 1997, International journal of clinical practice.

[534]  I C van Gelder,et al.  UvA-DARE ( Digital Academic Repository ) Efficacy , safety , and determinants of conversion of atrial fibrillation and flutter with oral amiodarone , 1997 .

[535]  H. Crijns,et al.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[536]  D P Zipes,et al.  Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. , 1996, Circulation.

[537]  M. Gold,et al.  Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. , 1996, The American journal of cardiology.

[538]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[539]  Mark A. Wood,et al.  Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[540]  D. Mehta,et al.  Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography. , 1996, Chest.

[541]  C. Schmitt,et al.  Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. , 1996, Journal of the American College of Cardiology.

[542]  G. Kay,et al.  Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. , 1996, Circulation.

[543]  K. Lindpaintner,et al.  Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[544]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[545]  J L Cox,et al.  An 8 1/2-year clinical experience with surgery for atrial fibrillation. , 1996, Annals of surgery.

[546]  Y. Nakamura,et al.  Predictors of ischemic stroke in non-rheumatic atrial fibrillation. , 1996, International journal of cardiology.

[547]  M. Santini,et al.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[548]  L. Kuller,et al.  Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[549]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[550]  F. Morady,et al.  Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. , 1996, The American journal of cardiology.

[551]  G. Lip,et al.  Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. , 1996, Circulation.

[552]  R. Harper,et al.  Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. , 1996, Circulation.

[553]  P. Sager,et al.  Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. , 1996, Journal of the American College of Cardiology.

[554]  S. Fihn,et al.  The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[555]  R. Schmieder,et al.  Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies , 1996 .

[556]  A. Proclemer,et al.  Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo‐controlled, double‐blind, multicenter clinical trial , 1996 .

[557]  G. Lip,et al.  Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. , 1996, American heart journal.

[558]  J. Soler‐Soler,et al.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. , 1996, Journal of the American College of Cardiology.

[559]  S Nattel,et al.  Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.

[560]  K. Ellenbogen,et al.  Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. , 1996, Journal of the American College of Cardiology.

[561]  R. Safford,et al.  F‐Amplitude, left atrial appendage velocity, and thromboembolic risk in nonrheumatic atrial fibrillation , 1996, Clinical cardiology.

[562]  V. Fuster,et al.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[563]  C. Tai,et al.  Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double‐blind, randomized trial , 1996, Journal of internal medicine.

[564]  E. Prystowsky,et al.  Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node. , 1996, The American journal of cardiology.

[565]  S. Connolly,et al.  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[566]  A. Sheikhzadeh,et al.  Detection of a Hypercoagulable State in Nonvalvular Atrial Fibrillation and the Effect of Anticoagulant Therapy , 1996, Thrombosis and Haemostasis.

[567]  P. Coumel,et al.  Drug therapy for prevention of atrial fibrillation. , 1996, The American journal of cardiology.

[568]  S. Hohnloser,et al.  Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. , 1996, The American journal of cardiology.

[569]  N. Kerin,et al.  The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. , 1996, Archives of internal medicine.

[570]  K. Ellenbogen,et al.  Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. , 1996, Circulation.

[571]  D K Owens,et al.  The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.

[572]  T E Cuddy,et al.  Atrial fibrillation and atrial flutter. , 1996, The Canadian journal of cardiology.

[573]  H. Crijns,et al.  Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. , 1995, Journal of cardiac failure.

[574]  P. Oettgen,et al.  Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. , 1995, Archives of internal medicine.

[575]  R. Sung,et al.  Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators. , 1995, Circulation.

[576]  M. Bamoshmoosh,et al.  Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study , 1995, Clinical cardiology.

[577]  S. Hohnloser,et al.  Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. , 1995, Journal of the American College of Cardiology.

[578]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[579]  A. Caruso,et al.  Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. , 1995, Archives of internal medicine.

[580]  M. Huttunen,et al.  Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). , 1995, The American journal of cardiology.

[581]  J. Boineau,et al.  Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. , 1995, The Journal of thoracic and cardiovascular surgery.

[582]  J L Cox,et al.  Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. , 1995, The Journal of thoracic and cardiovascular surgery.

[583]  A. Capucci,et al.  Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. , 1995, Chest.

[584]  W. Manning,et al.  Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.

[585]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[586]  W. Stevenson,et al.  Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. , 1995, The American journal of cardiology.

[587]  G. Lip,et al.  Coagulation activity is increased in the left atrium of patients with mitral stenosis. , 1995, Journal of the American College of Cardiology.

[588]  J. Thomas,et al.  Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. , 1995, American heart journal.

[589]  H. Matsuoka,et al.  Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. , 1995, Japanese circulation journal.

[590]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[591]  R. Baroffio,et al.  A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation , 1995 .

[592]  A. Camm,et al.  Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. , 1995, Journal of the American College of Cardiology.

[593]  A. Sheikhzadeh,et al.  Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. , 1995, The American journal of cardiology.

[594]  P. Oettgen,et al.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. , 1995, Journal of the American College of Cardiology.

[595]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[596]  A. Algra,et al.  Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group. , 1995, Stroke.

[597]  D P Zipes,et al.  Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. , 1995, Circulation.

[598]  R. Falk,et al.  Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. , 1995, American heart journal.

[599]  S. Cobbe,et al.  Chemical cardioversion of atrial fibrillation with intravenous dofetilide. , 1995, International journal of cardiology.

[600]  M. Chang,et al.  Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.

[601]  B. Hockings,et al.  Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. , 1995, The American journal of cardiology.

[602]  G. Koren,et al.  Pregnancy outcome after gestational exposure to amiodarone in Canada. , 1995, American journal of obstetrics and gynecology.

[603]  W. Manning,et al.  Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. , 1995, The American journal of cardiology.

[604]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[605]  Douglas L. Jones,et al.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[606]  R. Pistelli,et al.  Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[607]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[608]  Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence. , 1995, Coronary artery disease.

[609]  J. Alpert,et al.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. , 1992, Chest.

[610]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[611]  T. Binder,et al.  Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. , 1995, American heart journal.

[612]  R. Cebul,et al.  Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. , 1995, American heart journal.

[613]  A. Efthymiadis,et al.  Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. , 1995, Acta cardiologica.

[614]  S. Lévy,et al.  Paroxysmal atrial fibrillation: a need for classification. , 1995, Journal of cardiovascular electrophysiology.

[615]  J. Roelandt,et al.  Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events. , 1994, European heart journal.

[616]  P. Kligfield,et al.  Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. , 1994, The American journal of cardiology.

[617]  G. Ferrari,et al.  Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm , 1994, Pacing and clinical electrophysiology : PACE.

[618]  G. Feld,et al.  Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. , 1994, Circulation.

[619]  J. Blumenthal,et al.  Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. , 1994, The American journal of cardiology.

[620]  M. Niebauer,et al.  Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. , 1994, The New England journal of medicine.

[621]  H. Katayama,et al.  Contrast sonography for detection of vesicoureteral reflux , 1994, The Lancet.

[622]  D. Leung,et al.  Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[623]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[624]  W. Lien,et al.  Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism. , 1994, Chest.

[625]  R. M. Payne,et al.  Management of Arrhythmias in Patients with Severe Lung Disease , 1994 .

[626]  W. Manning,et al.  Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[627]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[628]  D. Fatkin,et al.  Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. , 1994, Circulation.

[629]  C. Schmitt,et al.  Initial Experience with Intracardiac Atrial Defibrillation in Patients with Chronic Atrial Fibrillation , 1994, Pacing and clinical electrophysiology : PACE.

[630]  J Haaksma,et al.  Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. , 1994, Clinical science.

[631]  G. Klein,et al.  Risk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives , 1994, Pacing and clinical electrophysiology : PACE.

[632]  Y. Rudy,et al.  Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. , 1994, Circulation research.

[633]  J. Hochman,et al.  Prognostic significance of left ventricular aneurysm in the Cardiac Arrhythmia Suppression Trial (CAST) population. , 1994, American heart journal.

[634]  R. Ganam,et al.  Clinical course of recent-onset atrial fibrillation treated with oral propafenone. , 1994, Chest.

[635]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[636]  Stroke Investigators.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[637]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[638]  D. Fatkin,et al.  Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. , 1994, Journal of the American College of Cardiology.

[639]  R. Peters,et al.  High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure. , 1994, Journal of the American College of Cardiology.

[640]  L. Lai,et al.  Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. , 1994, Chest.

[641]  W. Daniel,et al.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.

[642]  A. Capucci,et al.  A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. , 1994, International journal of cardiology.

[643]  M. Ovadia,et al.  Human experience with amiodarone in the embryonic period. , 1994, The American journal of cardiology.

[644]  D. Fatkin,et al.  Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. , 1994, Journal of the American College of Cardiology.

[645]  Ç. Erol,et al.  Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure. , 1994, International journal of cardiology.

[646]  J. Rothrock,et al.  Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. , 1994, Archives of internal medicine.

[647]  Y. Tseng,et al.  Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. , 1994, Cardiology.

[648]  [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison]. , 1994, Zeitschrift fur Kardiologie.

[649]  G. Ayers,et al.  Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. , 1994, Circulation.

[650]  R. Page,et al.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.

[651]  J L Cox,et al.  Hazards of postoperative atrial arrhythmias. , 1994, The Annals of thoracic surgery.

[652]  S. Zelenkofske,et al.  Value of the P‐Wave Signal‐Averaged ECG for Predicting Atrial Fibrillation After Cardiac Surgery , 1993, Circulation.

[653]  Eaft Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[654]  H. Crijns,et al.  Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. , 1993, Journal of the American College of Cardiology.

[655]  R. Grimm,et al.  Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. , 1993, Journal of the American College of Cardiology.

[656]  J. Halperin,et al.  Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1993, The American journal of cardiology.

[657]  A. Zbrozek,et al.  Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. , 1993, The American journal of cardiology.

[658]  H. Crijns,et al.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[659]  A. Laupacis,et al.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.

[660]  A. Madrid,et al.  Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. , 1993, European heart journal.

[661]  R. Poole,et al.  Left Atrial Spontaneous Echo Contrast Is Highly Associated With Previous Stroke in Patients With Atrial Fibrillation or Mitral Stenosis , 1993, Stroke.

[662]  J. Cohn,et al.  The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[663]  M. Enriquez-Sarano,et al.  Multiplane transesophageal echocardiography: image orientation, examination technique, anatomic correlations, and clinical applications. , 1993, Mayo Clinic proceedings.

[664]  A. Stead,et al.  Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. , 1993, Clinical Chemistry.

[665]  H. Krumholz,et al.  Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.

[666]  J. Tijssen,et al.  Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. , 1993, The American journal of cardiology.

[667]  M. Kotler,et al.  Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[668]  A. Harada,et al.  Successful combined operation for mitral stenosis and atrial fibrillation. , 1993, The Annals of thoracic surgery.

[669]  E. Antman,et al.  Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. , 1993, The American journal of cardiology.

[670]  K. Bailey,et al.  A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[671]  W. Walsh,et al.  Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. , 1993, Journal of the American College of Cardiology.

[672]  J. Rothrock,et al.  Ischemic stroke in patients with atrial fibrillation , 1993, Neurology.

[673]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[674]  G. Schlierf,et al.  Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. , 1993, Seminars in thrombosis and hemostasis.

[675]  D. Zipes,et al.  Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. , 1992, Journal of the American College of Cardiology.

[676]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[677]  G. Ewy.  Optimal technique for electrical cardioversion of atrial fibrillation. , 1992, Circulation.

[678]  H. Calkins,et al.  A Randomized Comparison of External and Internal Cardioversion of Chronic Atrial Fibrillation , 1992, Circulation.

[679]  Jeffrey S. Ginsberg,et al.  Use of antithrombotic agents during pregnancy. , 1992, Chest.

[680]  A. Constantinesco,et al.  Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. , 1992, European heart journal.

[681]  P. dos Santos,et al.  Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients. , 1992, The American journal of cardiology.

[682]  A. Capucci,et al.  Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. , 1992, The American journal of cardiology.

[683]  H. Crijns,et al.  Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.

[684]  H C Smith,et al.  Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[685]  S. Hohnloser,et al.  Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. , 1992, Journal of the American College of Cardiology.

[686]  R. Marinchak,et al.  Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. , 1992, The American journal of cardiology.

[687]  F. Loop,et al.  Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. , 1992, Journal of the American College of Cardiology.

[688]  P. Coumel.  Neural aspects of paroxysmal atrial fibrillation , 1992 .

[689]  U. Goldbourt,et al.  Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction , 1992 .

[690]  G. Guiraudon,et al.  The Pathology of Drug Resistant Lone Atrial Fibrillation in Eleven Surgically Treated Patients , 1992 .

[691]  J. A. Daniel,et al.  Exclusion of atrial thrombus by transesophageal echocardiography. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[692]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[693]  E. Prystowsky,et al.  Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome. , 1991, The American journal of cardiology.

[694]  J. Kluger,et al.  Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation , 1991 .

[695]  A. Camm,et al.  A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff‐Parkinson‐White Syndrome , 1991, Pacing and clinical electrophysiology : PACE.

[696]  E. Antman,et al.  Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.

[697]  S. Lévy,et al.  Predictors of In‐Hospital Mortality After DC Catheter Ablation of Atrioventricular Junction: Results of a Prospective, International, Multicenter Study , 1991, Circulation.

[698]  R. Kerber,et al.  Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. , 1991, Stroke.

[699]  B. Marino,et al.  Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. , 1991, European heart journal.

[700]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[701]  M. Laakso,et al.  The European Stroke Prevention Study , 1991, Neurology.

[702]  T. Takano,et al.  Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: endocrinologic silence. , 1991, Journal of the American College of Cardiology.

[703]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[704]  D. Singer,et al.  Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. , 1991, The American journal of medicine.

[705]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[706]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[707]  J. Hirsh.  Oral anticoagulant drugs. , 1991, The New England journal of medicine.

[708]  R. Lazzara,et al.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. , 1991, The New England journal of medicine.

[709]  E. Prystowsky,et al.  Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans. , 1991, Circulation research.

[710]  A. Pietersen,et al.  Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. , 1991, The American journal of cardiology.

[711]  P B Corr,et al.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[712]  P B Corr,et al.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[713]  P. Coumel,et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1991, European heart journal.

[714]  G. Dobb,et al.  Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. , 1991, The American journal of cardiology.

[715]  M Fukunami,et al.  Detection of Patients at Risk for Paroxysmal Atrial Fibrillation During Sinus Rhythm by P Wave‐Triggered Signal‐Averaged Electrocardiogram , 1991, Circulation.

[716]  G. Fontana,et al.  Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm , 1991 .

[717]  A. Labovitz,et al.  Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. , 1991, Journal of the American College of Cardiology.

[718]  I. V. Van Gelder,et al.  Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. , 1991, American heart journal.

[719]  J. Kluger,et al.  Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. , 1991, American Journal of Cardiology.

[720]  K. Lie,et al.  The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1990, Journal of the American College of Cardiology.

[721]  G. Feld.  Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? , 1990, Circulation.

[722]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[723]  M. Lesser.  Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias. , 1990, The American journal of cardiology.

[724]  David C. Anderson,et al.  Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation , 1990 .

[725]  G. Klein,et al.  Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. , 1990, Circulation.

[726]  S. Meterissian,et al.  Assessment of cardiac function in patients who were morbidly obese. , 1990, Surgery.

[727]  P. Harris,et al.  The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. , 1990, The Journal of thoracic and cardiovascular surgery.

[728]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[729]  T. Kamada,et al.  Increased intracardiovascular clotting in patients with chronic atrial fibrillation. , 1990, Journal of the American College of Cardiology.

[730]  L. Wilkins.  European Stroke Prevention Study. ESPS Group. , 1990, Stroke.

[731]  J. Bogousslavsky,et al.  Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation , 1990, Neurology.

[732]  E. Prystowsky,et al.  Occurrence of Atrial Fibrillation in Patients With Paroxysmal Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry , 1990, Pacing and clinical electrophysiology : PACE.

[733]  J. Alpert,et al.  Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. , 1990, American heart journal.

[734]  M. Frenneaux,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[735]  W. M. Smith,et al.  Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[736]  M. Horvat,et al.  Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. , 1990, The American journal of cardiology.

[737]  J. Rawles,et al.  What is meant by a "controlled" ventricular rate in atrial fibrillation? , 1990, British heart journal.

[738]  E. Antman,et al.  Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. , 1990, Journal of the American College of Cardiology.

[739]  A. Miller,et al.  Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. , 1990, American heart journal.

[740]  C. Giglioli,et al.  Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. , 1990, The Journal of emergency medicine.

[741]  L. Rydén,et al.  Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. , 1990, Journal of the American College of Cardiology.

[742]  P. Petersen.  Thromboembolic complications in atrial fibrillation. , 1990, Stroke.

[743]  M. Blombäck,et al.  Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. , 1990, Stroke.

[744]  I. V. Van Gelder,et al.  Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[745]  E. Pritchett,et al.  Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. , 1989, Circulation.

[746]  A. Adgey,et al.  Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. , 1989, The American journal of cardiology.

[747]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[748]  B. Buxton,et al.  Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? , 1989, The Journal of thoracic and cardiovascular surgery.

[749]  J. Kastrup,et al.  Cerebral Blood Flow before and after Cardioversion of Atrial Fibrillation , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[750]  E. Antman,et al.  Efficacy of intravenous propafenone for the acute management of atrial fibrillation. , 1989, The American journal of cardiology.

[751]  E. Michelson,et al.  Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[752]  S. Connolly,et al.  Usefulness of propafenone for recurrent paroxysmal atrial fibrillation. , 1989, The American journal of cardiology.

[753]  J. Kingma,et al.  Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1989, The American journal of cardiology.

[754]  J. Le Heuzey,et al.  [The natural history of 270 cases of Wolff-Parkinson-White syndrome in a survey of the general population]. , 1989, Archives des maladies du coeur et des vaisseaux.

[755]  W. Manning,et al.  Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.

[756]  J. Agmon,et al.  Atrial fibrillation. Cause and time of onset. , 1989, Archives of internal medicine.

[757]  R. Bryg,et al.  Effect of pregnancy on pressure gradient in mitral stenosis. , 1989, The American journal of cardiology.

[758]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[759]  J. Rees,et al.  Improved control of atrial fibrillation with combined pindolol and digoxin therapy. , 1989, European heart journal.

[760]  J. McMurray,et al.  Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[761]  Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[762]  J. Porterfield,et al.  Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. , 1989, The American journal of cardiology.

[763]  I. V. Van Gelder,et al.  Effects of flecainide on the atrial defibrillation threshold. , 1989, The American journal of cardiology.

[764]  S. Sandhu,et al.  Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. , 1989, The American journal of cardiology.

[765]  L. Rydén,et al.  Long-term efficacy of flecainide in paroxysmal atrial fibrillation. , 2009, Acta medica Scandinavica.

[766]  L. Rydén,et al.  Chronic atrial fibrillation. Long-term results of direct current conversion. , 2009 .

[767]  H. Crijns,et al.  Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. , 1988, The American journal of cardiology.

[768]  J Nyboe,et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[769]  C. Foster,et al.  Amiodarone in pregnancy. Case report and review of the literature. , 1988, International journal of cardiology.

[770]  E. Aliot,et al.  The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.

[771]  M. Shenasa,et al.  Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. , 1988, The American journal of cardiology.

[772]  R. Ruffy,et al.  Treatment of atrial tachyarrhythmias and preexcitation syndrome with flecainide acetate. , 1988, The American journal of cardiology.

[773]  S. Lévy,et al.  High energy transcatheter cardioversion of chronic atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[774]  J. Halperin,et al.  Atrial fibrillation and stroke: new ideas, persisting dilemmas. , 1988, Stroke.

[775]  P. Gates,et al.  Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. , 1988, Stroke.

[776]  S. Goldstein,et al.  Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. , 1988, Chest.

[777]  W. Daniel,et al.  Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. , 1988, Journal of the American College of Cardiology.

[778]  H. Crijns,et al.  Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome. , 1988, American heart journal.

[779]  J B Martins,et al.  Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. , 1988, Circulation.

[780]  G. Klein,et al.  Propafenone for prevention of recurrent atrial fibrillation. , 1988, The American journal of cardiology.

[781]  F L Meijler,et al.  Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[782]  L. E. Peterson,et al.  Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.

[783]  B. Gersh,et al.  Propafenone for paroxysmal atrial fibrillation. , 1988, The American journal of cardiology.

[784]  M. Allessie,et al.  Length of Excitation Wave and Susceptibility to Reentrant Atrial Arrhythmias in Normal Conscious Dogs , 1988, Circulation research.

[785]  D. Singer,et al.  Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits. , 1988, The New England journal of medicine.

[786]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[787]  P. Brugada,et al.  Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. , 1987, The American journal of cardiology.

[788]  C. Gyldensted,et al.  Silent cerebral infarction in chronic atrial fibrillation. , 1987, Stroke.

[789]  G. Taylor,et al.  Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. , 1987, The American journal of cardiology.

[790]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[791]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[792]  M. Brodsky,et al.  Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. , 1987, The American journal of cardiology.

[793]  M. Rubenfire,et al.  Amiodarone in the management of refractory atrial fibrillation. , 1987, Archives of internal medicine.

[794]  T. Ives,et al.  Mexiletine use in pregnancy and lactation. , 1987, American journal of obstetrics and gynecology.

[795]  R. Falk,et al.  Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. , 1987, Annals of internal medicine.

[796]  G. Rose,et al.  RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATION , 1987, The Lancet.

[797]  J. Goy,et al.  Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. , 1986, The American journal of cardiology.

[798]  J. Landry,et al.  Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting. , 1986, The American journal of cardiology.

[799]  R. Coleman,et al.  Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. , 1986, The American journal of cardiology.

[800]  M. Schlüter,et al.  Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. , 1986, Journal of the American College of Cardiology.

[801]  J. Alpert,et al.  Amiodarone for refractory atrial fibrillation. , 1986, The American journal of cardiology.

[802]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[803]  L. Horowitz,et al.  Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. , 1985, Journal of the American College of Cardiology.

[804]  M. Nicholls,et al.  Effect of enalapril on ventricular arrhythmias in congestive heart failure. , 1985, The American journal of cardiology.

[805]  M. Shenasa,et al.  Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndrome , 1985, Clinical cardiology.

[806]  R. Zupkis,et al.  Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias , 1985, Clinical pharmacology and therapeutics.

[807]  M. Allessie,et al.  Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation , 1985 .

[808]  P. Genton,et al.  Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism , 1984, Clinical pharmacology and therapeutics.

[809]  A. L. Wit,et al.  Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. , 1984, Circulation.

[810]  E. Williams.  A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[811]  T. Agner,et al.  A reevaluation of atrial fibrillation in thyrotoxicosis. , 1984, Danish medical bulletin.

[812]  B. Gersh,et al.  The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo. , 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[813]  E. V. Vaughan Williams.  A classification of antiarrhythmic actions reassessed after a decade of new drugs. , 1984, Journal of clinical pharmacology.

[814]  J. Pantridge,et al.  The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. , 1984, Circulation.

[815]  G. Ertl,et al.  Alpha-receptor restriction of coronary blood flow during atrial fibrillation. , 1983, The American journal of cardiology.

[816]  E. Michelson,et al.  The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. , 1983, American heart journal.

[817]  W. Kannel,et al.  Coronary heart disease and atrial fibrillation: the Framingham Study. , 1983, American heart journal.

[818]  G. Klein,et al.  Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. , 1983, American heart journal.

[819]  H. Petri,et al.  [Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation]. , 1983, Herz.

[820]  M. Rosen,et al.  The Relationship of Human Atrial Cellular Electrophysiology to Clinical Function and Ultrastructure , 1983, Circulation research.

[821]  J. Hobbins,et al.  Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. , 1983, The American journal of cardiology.

[822]  E. Michelson,et al.  Atrioventricular nodal conduction during atrial fibrillation in rabbit heart. , 1982, The American journal of physiology.

[823]  A. Goldberger,et al.  Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success. , 1982, American heart journal.

[824]  R. Kerber,et al.  The Effects of Atrial Fibrillation on Atrial Pressure‐ Volume and Flow Relationships , 1982, Circulation research.

[825]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[826]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[827]  D. W. Cheung.  Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia , 1981, Nature.

[828]  J. Karliner,et al.  Safety of electrical cardioversion in patients without digitalis toxicity. , 1981, Annals of internal medicine.

[829]  P. Boyden,et al.  The Effects on Atrial Electrophysiology and Structure of Surgically Induced Right Atrial Enlargement in Dogs , 1981, Circulation research.

[830]  R. Kerber,et al.  Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. , 1981, The New England journal of medicine.

[831]  M. Ehrenfeld,et al.  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1981, Archives of internal medicine.

[832]  J. Stockigt,et al.  Atrial fibrillation and arterial embolism in hyperthyroidism. , 1981, Australian and New Zealand journal of medicine.

[833]  F. Dunn,et al.  Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. , 1981, The American journal of cardiology.

[834]  D. W. Cheung.  Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea‐pig. , 1981, The Journal of physiology.

[835]  J. Delahaye,et al.  Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation. , 1981, European heart journal.

[836]  E. Vitolo,et al.  Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. , 1981, Acta cardiologica.

[837]  C. Robertson,et al.  Extreme tachycardia complicating the use of disopyramide in atrial flutter. , 1980, British heart journal.

[838]  R. Crampton,et al.  Accepted, controversial, and speculative aspects of ventricular defibrillation. , 1980, Progress in cardiovascular diseases.

[839]  A L Waldo,et al.  Characterization of Atrial Flutter: Studies in Man After Open Heart Surgery Using Fixed Atrial Electrodes , 1979, Circulation.

[840]  L. Geddes,et al.  Electrocardiographic and serum enzymic alterations associated with cardiac alterations induced in dogs by single transthoracic damped sinusoidal defibrillator shocks of various strengths. , 1979, American heart journal.

[841]  A. Toft,et al.  Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. , 1979, The American journal of cardiology.

[842]  P. Thompson,et al.  EMBOLISM IN THYROTOXIC ATRIAL FIBRILLATION , 1979, The Medical journal of Australia.

[843]  B. Maron,et al.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.

[844]  J. Staffurth,et al.  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1977, British medical journal.

[845]  G A Ewy,et al.  Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. , 1976, The American journal of cardiology.

[846]  G. Rosenhamer,et al.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. , 1975, British heart journal.

[847]  O. Paes de Almeida,et al.  The cardiac muscle in the pulmonary vein of the rat: a morphological and electrophysiological study. , 1975, Journal of morphology.

[848]  G A Ewy,et al.  Myocardial Necrosis from Direct Current Countershock: Effect of Paddle Electrode Size and Time Interval Between Discharges , 1974, Circulation.

[849]  A. Louhija,et al.  Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion , 1974, Clinical pharmacology and therapeutics.

[850]  T. Petty,et al.  Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. , 1973, Chest.

[851]  G. Ewy,et al.  Transthoracic impedance to defibrillator discharge. Effect of electrode size and electrode-chest wall interface. , 1973, Journal of electrocardiology.

[852]  R. Barr,et al.  Spread of excitation from the atrium into thoracic veins in human beings and dogs. , 1972, The American journal of cardiology.

[853]  D. Zipes,et al.  Electrical properties of the thoracic veins. , 1972, The American journal of cardiology.

[854]  S. Olsson,et al.  Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. , 2009, Acta medica Scandinavica.

[855]  J. Dale,et al.  Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study. , 1971, British heart journal.

[856]  L McDonald,et al.  Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise. , 1971, British heart journal.

[857]  L. Dreifus,et al.  Ventricular Fibrillation: A Possible Mechanism of Sudden Death in Patients with Wolff‐Parkinson‐White Syndrome , 1971, Circulation.

[858]  A. Wing,et al.  Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate. , 1970, British heart journal.

[859]  A. Louhija,et al.  Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation. , 1970, British heart journal.

[860]  E. Flensted-Jensen.  Wolff-Parkinson-White syndrome. A long-term follow-up of 47 cases. , 2009 .

[861]  O. Orning,et al.  The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.

[862]  H. Åberg,et al.  Direct current countershock complications. , 2009, Acta medica Scandinavica.

[863]  E. W. Hancock,et al.  Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. , 1968, Annals of internal medicine.

[864]  D. Evans,et al.  Long-term results of DC reversion of atrial fibrillation. , 1968, British heart journal.

[865]  D. Wood,et al.  Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine. , 1968, British heart journal.

[866]  G. Cramér.  Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. , 1968, Acta medica Scandinavica. Supplementum.

[867]  B. Lown,et al.  The use of quinidine in cardioversion. , 1967, The American journal of cardiology.

[868]  H. Nathan,et al.  The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. , 1966, Circulation.

[869]  B. Lown,et al.  Cardioversion and Digitalis Drugs: Changed Threshold to Electric Shock in Digitalized Animals , 1965, Circulation research.

[870]  R. Langendorf,et al.  Ventricular Response in Atrial Fibrillation: Role of Concealed Conduction in the AV Junction , 1965, Circulation.

[871]  F. Epstein,et al.  Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, Michigan , 1965, Circulation.

[872]  L. Dreifus,et al.  COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK. , 1964, JAMA.

[873]  J. .. Abildskov,et al.  Observations on the Ventricular Dysrhythmia Associated with Atrial Fibrillation in the Dog Heart , 1964, Circulation research.

[874]  W. Phair.  FAMILIAL ATRIAL FIBRILLATION. , 1963, Canadian Medical Association journal.

[875]  B. Lown,et al.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. , 1963, The New England journal of medicine.

[876]  B. Lown,et al.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. , 1986, JAMA.

[877]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[878]  F. London,et al.  Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis. , 1954, American heart journal.

[879]  W. Evans,et al.  LONE AURICULAR FIBRILLATION , 1954, British heart journal.

[880]  D. Scherf,et al.  Mechanism of flutter and fibrillation. , 1951, A.M.A. archives of internal medicine.

[881]  S. A. Levine,et al.  Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. , 1949, The American journal of medicine.

[882]  D. Scherf,et al.  Experimental studies on auricular flutter and auricular fibrillation. , 1948, American heart journal.

[883]  R. Ashman,et al.  Auricular fibrillation with aberration simulating ventricular paroxysmal tachycardia. , 1947, American heart journal.

[884]  S. Bellet,et al.  Clinical disorders of the heart beat. , 1946, Clinics.

[885]  J. Gunning,et al.  Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine ' , 2022 .

[886]  Rimm,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.